- Home
- / Pharmesis International
Pharmesis International
Stock Price
$0.6
2024-10-29
Market Capitalization
$18.7 M
2024-10-29
Revenue
¥43.8 M
FY, 2025
Pharmesis International Summary
Company Summary
- Overview
- Pharmesis International is a company that produces and, sells medicine formulated products for the treatment of illnesses relating to the liver and gall bladder. It offers health supplements, chemical drugs, antibiotics, biological raw products, etc.
- Type
- Public
- Status
- Active
- Founded
- 1996
- Website
- http://www.pharmesis.com
- Cybersecurity rating
Table of Contents
Pharmesis International Financials
Summary Financials
- Revenue (FY, 2025)
- ¥43.8M
- Gross profit (FY, 2025)
- ¥20.8M
- Net income (FY, 2025)
- (¥4.3M)
- Cash (FY, 2025)
- ¥4.3M
- EBIT (FY, 2025)
- (¥3.3M)
- Enterprise value
- $30.1M
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026